T-cell bispecifics in AML: ongoing challenges and future outlooks VJHemOnc – Video Journal of Hematology & HemOnc 2:22 1 year ago 340 Скачать Далее
Novel immunotherapies in AML and insights into the future of the treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 2:33 7 months ago 125 Скачать Далее
Borresen M6 $550,000 Loudspeakers #audioequipment #loudspeaker #highendaudio Jay's Audio Lab 0:34 4 hours ago 1 102 Скачать Далее
Looking forward to ISAL 2023 VJHemOnc – Video Journal of Hematology & HemOnc 1:01 1 year ago 115 Скачать Далее
T-cell evolution in AML and its impact on the efficacy of bispecific antibodies VJHemOnc – Video Journal of Hematology & HemOnc 1:05 2 years ago 113 Скачать Далее
CAR T-cell toxicity: CRS, ICANS and prolonged cytopenias VJHemOnc – Video Journal of Hematology & HemOnc 3:43 3 years ago 1 345 Скачать Далее
ISAL 2023: meeting highlights VJHemOnc – Video Journal of Hematology & HemOnc 1:19 1 year ago 180 Скачать Далее
How bispecific antibodies contribute to T-cell activation in AML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 225 Скачать Далее
Immunotherapy and its dependence on T-cells VJHemOnc – Video Journal of Hematology & HemOnc 1:10 6 years ago 199 Скачать Далее
BiTES for the treatment of acute myeloid leukemia (AML) - results with AMG 330 in ex vivo study VJHemOnc – Video Journal of Hematology & HemOnc 1:44 7 years ago 552 Скачать Далее
New strategies in AML: checkpoint inhibitors combined with T-cell engagers VJHemOnc – Video Journal of Hematology & HemOnc 1:20 6 years ago 157 Скачать Далее
AML clinical trials: early stage vs. relapse/refractory patients VJHemOnc – Video Journal of Hematology & HemOnc 0:39 6 years ago 222 Скачать Далее
Investigator initiated trials with CAR T cells: Future development (Marion Subklewe) Nationale Akademie der Wissenschaften Leopoldina 22:36 3 months ago 155 Скачать Далее
An update on CAR-T therapy in AML: challenges & emerging strategies VJHemOnc – Video Journal of Hematology & HemOnc 2:23 2 years ago 466 Скачать Далее
Modulation of AMG 330-mediated T-cell proliferation and cytotoxicity VJHemOnc – Video Journal of Hematology & HemOnc 2:45 5 years ago 64 Скачать Далее
Challenges in developing CAR-T therapy for AML VJHemOnc – Video Journal of Hematology & HemOnc 1:44 1 year ago 175 Скачать Далее
Exploring strategies to mitigate T-cell exhaustion: treatment-free intervals & small molecules VJHemOnc – Video Journal of Hematology & HemOnc 2:11 1 year ago 169 Скачать Далее
CD33-TIM3 dual CAR T-cells enhance specificity of AML treatment VJHemOnc – Video Journal of Hematology & HemOnc 1:43 7 months ago 263 Скачать Далее
Redirecting T-cell cytotoxicity and proliferation VJHemOnc – Video Journal of Hematology & HemOnc 2:18 5 years ago 69 Скачать Далее
Target antigens for T-cell engager therapies in ALL and AML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 6 years ago 126 Скачать Далее
